COLLEGIUM PHARMACEUTICAL, INC

COLL

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001746251-26-000004
Filing date: Mar 5, 2026
Earliest execution date: Mar 3, 2026

Summary

Type

Sell

Net shares

-49,976

% of shares

-41.05%

Amount (USD)

$2,019,436

Insider confidence score

8.8 out of 100

Positive

  • Under Rule 10b5-1 trading plan

Negative

  • Extreme scheduled sell (≥25% of shares)
  • Very large sell amount ($1M+)

Stock transactions

Transaction 1

Security

Common Stock

Action

Sell

Date

2026-03-03

Code

S

Net shares

-46,417.0

Price per Share

$40.36

Amount (USD)

$1,873,557.22

Acquired/Disposed

Disposed

Shares Owned Before

121,746.0

Shares Owned After

75,329.0

Transaction 2

Security

Common Stock

Action

Sell

Date

2026-03-03

Code

S

Net shares

-3,559.0

Price per Share

$40.99

Amount (USD)

$145,879.50

Acquired/Disposed

Disposed

Shares Owned Before

75,329.0

Shares Owned After

71,770.0

Filing's footnotes

1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 3, 2025.

2. The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.835 to $40.82, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.

3. The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.84 to $41.35, inclusive.

ℹ️ Filed under Rule 10b5-1 trading plan

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.